LFCR · Lifecore Biomedical, Inc. De
$4.72
-0.01 (-0.21%)
At close · Aug 14
Market Cap
$178.67M
Shares
37.85M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ryan D. Lake | Executive Vice President, Chief Financial Officer | $4,302,439 |
| Thomas D. Salus | Chief Legal and Administrative Officer | $4,098,554 |
| Paul Josephs | President and Chief Executive Officer | $1,115,305 |
| John D. Morberg | Former Executive Vice President, Chief Financial Officer | $756,194 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Paul Josephs | President and Chief Executive Officer | $10,247,057 |
| James G. Hall | Former President and Chief Executive Officer | $2,491,413 |
| John D. Morberg | Former Executive Vice President, Chief Financial Officer | $1,293,656 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| James G. Hall | Former President and Chief Executive Officer | $1,764,213 |
| John D. Morberg | Former Executive Vice President, Chief Financial Officer | $927,095 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Albert D. Bolles | Former President and Chief Executive Officer | $956,810 |
| James G. Hall | Former President and Chief Executive Officer | $913,028 |
| John D. Morberg | Executive Vice President, Chief Financial Officer, and Secretary | $618,031 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Albert D. Bolles | Former President and Chief Executive Officer | $1,131,299 |
| James G. Hall | President and Chief Executive Officer | $860,757 |
| John D. Morberg | Executive Vice President, Chief Financial Officer, and Secretary $ | $688,078 |
| Brian F. McLaughlin | Former Vice President of Finance and Administration, Chief Financial Officer | $597,694 |
| Timothy P. Burgess | Former Senior Vice President of Supply Chain of Curation Foods and Vice President of Landec | $520,063 |
| Dawn Kimball | Former Senior Vice President of Human Resources and Chief People Officer | $454,352 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Albert D. Bolles | Former President and Chief Executive Officer | $980,309 |
| James G. Hall | Chief Executive Officer of the Company, Former Vice President of the Company and President of Lifecore | $960,196 |
| Gregory S. Skinner | Former Executive Vice President of Finance and Administration, Chief Financial Officer | $786,481 |
| Timothy P. Burgess | Former Senior Vice President of Supply Chain of Curation Foods and Vice President of Landec | $577,853 |
| Brian F. McLaughlin | Former Vice President of Finance and Administration, Chief Financial Officer | $496,933 |
| Dawn Kimball | Former Senior Vice President of Human Resources and Chief People Officer | $380,954 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Albert D. Bolles | President and Chief Executive Officer | $1,004,966 |
| Gregory S. Skinner | Former Executive Vice President of Finance and Administration, Chief Financial Officer | $859,115 |
| James G. Hall | President of Lifecore Biomedical and Vice President of Landec | $842,841 |
| Brian F. McLaughlin | Former Vice President of Finance and Administration, Chief Financial Officer | $603,035 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| James G. Hall | President of Lifecore Biomedical and Vice President of Landec | $1,046,150 |
| Gregory S. Skinner | Former Executive Vice President of Finance and Administration, Chief Financial Officer | $741,834 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Christopher S. Kiper | Series A Preferred Director | Appointed | 2026-06-05 |
| Jason Aryeh | Series A Preferred Director | Appointed | 2026-06-05 |
| Joshua E. Schechter | Director | Appointed | 2026-06-05 |
| Nelson Obus | Director | Appointed | 2026-06-05 |
| Matthew E. Korenberg | Director | Appointed | 2026-06-05 |
| Paul Josephs | Director | Appointed | 2026-06-05 |
| Paul H. Johnson | Director | Appointed | 2026-06-05 |
| Humberto C. Antunes | Director | Appointed | 2026-06-05 |
| Katrina L. Houde | Director | Appointed | 2026-06-05 |
| John D. Morberg | Chief Financial Officer and Secretary | Terminated | 2024-08-29 |
| Ryan D. Lake | Chief Financial Officer and Secretary | Appointed | 2024-08-29 |
| Matthew Korenberg | director | Appointed | 2024-08-21 |
| Humberto C. Antunes | director | Appointed | 2024-08-21 |
| Paul H. Johnson | director | Appointed | 2024-08-21 |
| Jason Aryeh | director | Appointed | 2024-08-21 |
| Paul Johnson | Class 2 director on the Board | Appointed | 2024-07-01 |
| Matthew Korenberg | Class 1 director on the Board | Appointed | 2024-07-01 |
| Humberto Antunes | Class 1 director on the Board | Appointed | 2024-07-01 |
| Paul Josephs | director of the Company | Appointed | 2024-05-22 |
| Paul Josephs | President and Chief Executive Officer | Appointed | 2024-05-22 |
| James G. Hall | director of the Company | Resigned | 2024-05-22 |
| James G. Hall | director of the Company and ceased serving as the Company's President and Chief Executive Officer | Resigned | 2024-05-22 |
| Paul Josephs | President and Chief Executive Officer | Appointed | 2024-03-21 |
| Christopher Kiper | Series A Preferred Director | Appointed | 2023-01-10 |
| Nathaniel Calloway | Series A Preferred Director | Appointed | 2023-01-10 |
Key facts
CIK
1005286
CUSIP
514766104
13F (30d)
99 filings
97 filers
Visit website
Investor relations